Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Corvus Pharma Com
(NQ:
CRVS
)
4.300
+0.150 (+3.61%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Corvus Pharma Com
< Previous
1
2
3
4
5
Next >
Corvus Pharmaceuticals to Present at the Jefferies Healthcare Conference
May 31, 2023
From
Corvus Pharmaceuticals, Inc.
Via
GlobeNewswire
3 High-Potential Penny Stocks to Buy Now
May 31, 2023
When it comes to penny stocks to buy now, be aware of the risks. While some of these little guys can rocket, some will be duds.
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's Intraday Session
May 17, 2023
Via
Benzinga
Why Doximity Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
May 17, 2023
Gainers
Via
Benzinga
Corvus Pharmaceuticals Earnings Preview
March 27, 2023
Via
Benzinga
Corvus Pharma's HIV Candidate Shows Potential To Prevent Virus Re-Emergence
February 21, 2023
Via
Benzinga
Corvus Pharmaceuticals to Present New CPI-818 Data at the International Conference on Malignant Lymphoma
May 17, 2023
From
Corvus Pharmaceuticals, Inc.
Via
GlobeNewswire
Why Venus Concept Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
May 15, 2023
Gainers NeoGames S.A. (NASDAQ: NGMS) shares climbed 113.3% to $27.38 as the company agreed to be acquired by Aristocrat Leisure Limited for $29.50 per share in cash.
Via
Benzinga
Why Are Corvus Pharmaceuticals Trading Higher Today
May 10, 2023
In its Q1 earnings release, Corvus Pharmaceuticals Inc (NASDAQ: CRVS) revealed updated data from the Phase 1/1b trial evaluating single-agent therapy with CPI-818 in patients with
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
May 10, 2023
Via
Benzinga
Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2023 Financial Results
May 08, 2023
From
Corvus Pharmaceuticals, Inc.
Via
GlobeNewswire
7 High-Potential Penny Stocks in the Biotech Sector
May 04, 2023
Most of the biggest biotech stocks on the market started off as unknown penny stocks. Here are seven hot ones to consider.
Via
InvestorPlace
Corvus Pharmaceuticals to Provide Business Update and Report First Quarter 2023 Financial Results on May 8, 2023
April 20, 2023
Company to host conference call and webcast at 4:30 pm ET / 1:30 pm PT
From
Corvus Pharmaceuticals, Inc.
Via
GlobeNewswire
Corvus Pharmaceuticals Presents New CPI-818 Data Demonstrating the Potential of ITK Inhibition as a Treatment for Solid and Hematologic Cancers at the American Association for Cancer Research (AACR) Annual Meeting
April 17, 2023
From
Corvus Pharmaceuticals, Inc.
Via
GlobeNewswire
The 3 Best Biotech Stocks Under $1 to Buy for April
April 04, 2023
While risky, here are some of the best biotech stocks under $1, with solid catalysts, investors may want to consider.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
April 04, 2023
Via
Benzinga
CPI-818 Data Highlights Potential for ITK Inhibition as a New Immunotherapy Approach for the Treatment of T Cell Lymphoma
April 03, 2023
From
Corvus Pharmaceuticals, Inc.
Via
GlobeNewswire
Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2022 Financial Results
March 28, 2023
From
Corvus Pharmaceuticals, Inc.
Via
GlobeNewswire
Corvus Pharmaceuticals to Provide Business Update and Report Fourth Quarter and Full Year 2022 Financial Results on March 28, 2023
March 21, 2023
Company to host conference call and webcast at 4:30 pm ET / 1:30 pm PT
From
Corvus Pharmaceuticals, Inc.
Via
GlobeNewswire
Corvus Pharmaceuticals to Present New CPI-818 Data Demonstrating the Potential of ITK Inhibition as a Treatment for Solid Tumors at the American Association for Cancer Research (AACR) Annual Meeting
March 14, 2023
Preclinical data builds on objective tumor responses achieved in the ongoing Phase 1/1b clinical trial of CPI-818 for the treatment of refractory T cell lymphoma and further supports its broad...
From
Corvus Pharmaceuticals, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
February 21, 2023
Via
Benzinga
Corvus Pharmaceuticals Announces New Data Demonstrating CPI-818’s (ITK Inhibitor) Potential to Block HIV Latency Reversal
February 21, 2023
From
Corvus Pharmaceuticals, Inc.
Via
GlobeNewswire
$1 Million Bet On BioCardia? Check Out These 4 Penny Stocks Insiders Are Buying
December 21, 2022
The Dow Jones settled higher on Tuesday after recording losses for four straight sessions. Investors, meanwhile, focused on some notable insider trades.
Via
Benzinga
4 Penny Stocks Insiders Are Buying: Getaround, Corvus Pharmaceuticals And More
December 16, 2022
The Dow Jones closed lower by over 700 points on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern...
Via
Benzinga
Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session
December 13, 2022
Gainers OpGen, Inc. (NASDAQ: OPGN) shares surged 220% to $0.3994 after the company announced topline data from its Unyvero urinary tract infections (UTI) clinical trial.
Via
Benzinga
Corvus Pharmaceuticals Presents Updated Data from CPI-818 (ITK Inhibitor) Phase 1/1b Clinical Trial at the 64th American Society of Hematology (ASH) Annual Meeting & Exposition
December 12, 2022
From
Corvus Pharmaceuticals, Inc.
Via
GlobeNewswire
Corvus Pharmaceuticals to Host Investor Conference Call and Webcast on December 12, 2022
December 05, 2022
Event will focus on CPI-818 (ITK inhibitor) clinical development and will take place at 4:30 pm ET / 1:30 pm PT
From
Corvus Pharmaceuticals, Inc.
Via
GlobeNewswire
James Rosenbaum Presented the Distinguished Service Award by the American College of Rheumatology
November 14, 2022
From
Corvus Pharmaceuticals, Inc.
Via
GlobeNewswire
Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2022 Financial Results
November 03, 2022
From
Corvus Pharmaceuticals, Inc.
Via
GlobeNewswire
Corvus Pharmaceuticals to Present Updated CPI-818 (ITK Inhibitor) Data at the 64th American Society of Hematology (ASH) Annual Meeting & Exposition
November 03, 2022
Company to host conference call and webcast on December 12, 2022 at 4:30 pm ET / 1:30 pm PT
From
Corvus Pharmaceuticals, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.